Hard-hit cannabinoid firms in the US and Canada are reassessing their market strategies, restructuring, and downsizing – in some cases with significant job cuts – as the market remains volatile
Written by Lorraine Mullaney || 8th July 2020 || News analysis | Companies | Canada North America United States